Tag | Content |
---|
EnhancerAtlas ID | HS055-00281 |
Organism | Homo sapiens |
Tissue/cell | FT33 |
Coordinate | chr1:65893690-65895540 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Lhx3 | MA0135.1 | chr1:65895422-65895435 | AATTAATTAATTT | - | 6.92 | POU6F1 | MA0628.1 | chr1:65895423-65895433 | ATTAATTAAT | + | 6.02 | POU6F1 | MA0628.1 | chr1:65895423-65895433 | ATTAATTAAT | - | 6.02 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_13785 | chr1:65893666-65897155 | CD34_Primary_RO01536 | SE_36400 | chr1:65894681-65897043 | HMEC | SE_38328 | chr1:65893812-65898050 | HUVEC | SE_46388 | chr1:65893579-65897768 | Osteoblasts | SE_64205 | chr1:65894764-65896934 | HSMM | SE_65160 | chr1:65894771-65896536 | NHEK |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I065428 | chr1 | 65894640 | 65896906 |
|
Enhancer Sequence | CAGCCATGCT CATTTGTTTA TGAATTATCT TTGGCTGCTT TTGCATTGCT CTGCCAATTA 60 TCTTTGGCAG AGTTGAGTAG TTGAGATAGT CTTTATGGCT TGCAGATCCT CGTTATTTAC 120 TCTTTGGCCC TTTATAGAAA AAGTTGGCCC ACCCCTGGCC TATGTATTTA TTGAATTGTA 180 TATATTTAAT ATTTACATTT TATATATAAA CAAGGTTTCT TGTACATTAA TATTTCTCTT 240 AGTTGGATAT CGGTGGCTTA CTATGAATGA AAACATAGAG TCAGATTGTT TTTCACAAAA 300 CTGTCACTGT ATTCCAGGAA AAATTAAGAG TTCTTGGCTG TGGATATGTA AGGTGACATA 360 TCTATTCCAA ACCCCTTCCC CTCTCTGTGT CTCCTTTCTC ACTGTTGAAA GAAGGGCTTT 420 GAAGTAGAGA ATGTCTAAGG GCTACTTCCC ACAATATTGT TTGGTGATTC TTGAAACATA 480 CTATCATCCC TCTAGTTTAA AATCAGGGGT CCAAATCCAC TGTTTCCATC CTGAGTCCTC 540 TTGAAGGACA CATTCCCTTC TTGCCTTTTG GTTGCCTAGA TCTGTGGCTG GAATGGGAGG 600 CTTTCATTAG TGTGGCTTCA TCCCAACTCC TGCTTGTAGG TGCTGTCTGG GCGTATCTGT 660 GTGATTACAG TATTGTGGTG ATATGAATTA TTGTAGTGTA TATATAAAAA TGAGCAGAGA 720 CTTTTTTTTT CTTAAGAAAT GAAGCATAAG AAATGTCTGA TGGAGAAAAA AAGATTATTT 780 TTGAAGTACT GATAGAGAAA ATACTGTTGG AAACCAGATG GCAATTTTTT TTTTATAATT 840 GCAAAATGTT GAAATTTGGG AGGAAAACAG TTTTGTTTTG TTTTTGCATT ACACTATTAA 900 TTGTGAGCTC TTATAATGAA GATCAAAGTA CATCTAAGCT TTTCACTAGT GAGCATATTT 960 ATTTTCATGC CTTCCGTACT TAAAATTTAT TTATTATTTT ATTCATTTAA CAAGTATAAA 1020 TGGAGTACAT CATTCTAGGC CCTGGAGATA AATGGCGTTT GATCAAGACT AATCTATCAG 1080 ATGGGAATAA GTGTTGTGCA GAAAGTTCAA AGAGGGTGGT ATGTTCGAGG GTGACCTGGG 1140 GTACATTAGA ATAGATGACC AGGGAAAGTT CTGCTTTTAG AAAGGAATCT GTCAGTTTAG 1200 ATCACATGGT ATGAAGGAGT CAGCCAATGA GAAGATCATG GGGAAGGACA TTGCAAGCAG 1260 GGGGCACAGC TAGCGCAAAG GCCCCAGGAT AACAGCTATG AGCTCAAGAG TGTTCAAGGG 1320 ACAGAAAAAA GGCTGGTGTG GCTACAGATT AAGCAAATGA AGGGAAAAGA GTACAAAATG 1380 AATGGAAGAA GTAGATAATA CCAGACCATA AAGGCTTTGT AGGCTAGGGC AAGGAATTTA 1440 GGGTTTATTC TAAGCTCTTA AAAGGTTTCA AGCATGCGTG CACTCAAAAG ATCTTTACCG 1500 AACTAGCTTT TGCAAGACAC TCTACTATGT TCTATAGGGA AGGCAGAAAT GACCAAGTTA 1560 AAATTCTGTC TTTAAAGAAA TTGTGGCTCA GTGGTACAGA AAACAGTAAA GTTTCTAGGG 1620 TATATATTAT ATAGTGGCTT CTTAACACAA TATAAGCTAC CTACATAGTA ATTTTAAAAT 1680 TATCACTACT TATCTATCCC TGGTAGAAAT CATCTTATGT TCTAATATTC ACAATTAATT 1740 AATTTTTTGA CCTAAACATT TAAAATAGCA ATGATTTTGA AATAGTAGTA TGTCTTTCAT 1800 TTAAAATGTA ACTGTTACTT TTCTTTTTGG ATTTTGCCTG GGTCCAACTG 1850
|